European Court of Auditors - Vital Signs

Sign in Subscribe

European Court of Auditors

A collection of 5 posts

Cancer Leagues call for overhaul of EU drug pricing transparency rules

Access to Medicine

Cancer Leagues call for overhaul of EU drug pricing transparency rules

A new report from the Association of European Cancer Leagues says the EU’s Transparency Directive is no longer fit for purpose and is worsening inequalities in access to cancer medicines

Audit exposes weak monitoring and funding doubts in EU cancer strategy

Audit exposes weak monitoring and funding doubts in EU cancer strategy

An audit by the European Court of Auditors warns that Europe’s Beating Cancer Plan lacks clear targets, monitoring mechanisms and long-term funding certainty

Inside EU Health: EU auditors call for clearer health spending; EU media law revision opens for consultation; launch OECD cardio report

Inside EU Health

Inside EU Health: EU auditors call for clearer health spending; EU media law revision opens for consultation; launch OECD cardio report

EU auditors urge clearer health spending; EU media law revision opens door to stronger pubic health provisions; ‘State of Cardiovascular Health in the EU’ launch

EU auditors urge clearer separation of health spending in €10.7bn crisis plan

EU auditors urge clearer separation of health spending in €10.7bn crisis plan

EU auditors raise concerns over the Commission’s plans to expand the civil protection mechanism, warning that health funding needs clearer boundaries, stronger coordination and greater budgetary transparency.

Auditors say the EU must strengthen its response to critical medicine shortages

Critical medicines

Auditors say the EU must strengthen its response to critical medicine shortages

In a special report, published today (17 September), the European Court of Auditors (ECA) warns that critical medicine shortages continue to arise, posing a threat to health across the EU. “Medicine shortages can have severe consequences for patients, compromise public health and come at a high cost for doctors, pharmacies